A5102865007- Antifungal resistance and susceptibility
- Antibiotics Pharmacokinetics and Efficacy
- Bacterial Identification and Susceptibility Testing
- Oral microbiology and periodontitis research
- Diagnosis and treatment of tuberculosis
- Tuberculosis Research and Epidemiology
- Clostridium difficile and Clostridium perfringens research
- Antimicrobial Resistance in Staphylococcus
- Pregnancy and Medication Impact
- Gout, Hyperuricemia, Uric Acid
- Pharmaceutical and Antibiotic Environmental Impacts
- Fungal Infections and Studies
- Antibiotic Resistance in Bacteria
- Infectious Diseases and Tuberculosis
- Spondyloarthritis Studies and Treatments
All India Institute of Medical Sciences
2023-2024
Drug-resistant Acinetobacter baumannii is an emerging threat. This study has been conducted to observe the efficacy of eravacycline along with RND-efflux pump system. A cross-sectional was done collecting 48 clinical isolates baumannii. MICs 15 antibiotics were detected BMD tigecycline and eravacycline. PCR products drug-resistant regulatory genes sequenced analyzed. Of total Isolates, 35 (72.91%) XDR 13 (27.08%) MDR. Out all, 60.41% found be susceptible by according both FDA EUCAST...
Introduction. Invasive mucormycosis (IM) is a potentially fatal infection caused by fungi of the order Mucorales. Histopathology, culture, and radiology are mainstays diagnosis, but they not sufficiently sensitive, resulting in delayed diagnosis intervention. Recent studies have shown that PCR-based techniques can be promising way to diagnose IM.Hypothesis/Gap Statement. Early fungal infections using molecular diagnostic improve patient outcomes, especially invasive mucormycosis.Aim. The aim...
Reactive arthritis is included in the spectrum of seronegative spondyloarthritides, occurring secondary to triggers genitourinary and gastrointestinal tract infections. We describe two cases sexually acquired reactive genital infection by Chlamydia trachomatis, diagnosed in-house polymerase chain reaction performed on first void urine. Both patients were managed with a combined approach short course antibiotics, immunosuppressive agents, biologicals surgical intervention.
Background Tuberculosis (TB) remains an important public health problem worldwide. Risk of acquiring TB in patients diagnosed with cancers high and can result due to reactivation or reinfection. We share the experience a large tertiary care hospital. Materials Methods Clinical samples from presumptive while on cancer therapy were tested by smear Ziehl–Neelsen (ZN) staining, GeneXpert MTB/RIF (Gx), polymerase chain reaction (PCR), liquid culture (MGIT 960) January 1, 2019, December 31, 2022....